STRS Ohio’s MaxCyte MXCT Stock Holding History

STRS Ohio’s Portfolio MXCT Stock Details MXCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-129,500	Closed	-$91K	–	2264
2026 Q1	$91K	Hold	129,500	–	–	﹤0.01%	1805
2025 Q4	$201K	Hold	129,500	–	–	﹤0.01%	1514
2025 Q3	$205K	Hold	129,500	–	–	﹤0.01%	1521
2025 Q2	$282K	Buy	129,500 +9,200	+8%	+$22.3K	﹤0.01%	1531
2025 Q1	$328K	Hold	120,300	–	–	﹤0.01%	1364
2024 Q4	$500K	Hold	120,300	–	–	﹤0.01%	1205
2024 Q3	$468K	Hold	120,300	–	–	﹤0.01%	1296
2024 Q2	$472K	Buy	120,300 +12,300	+11%	+$52.9K	﹤0.01%	1284
2024 Q1	$452K	Sell	108,000 -6,900	-6%	-$32.4K	﹤0.01%	1313
2023 Q4	$540K	Sell	114,900 -6,300	-5%	-$24.5K	﹤0.01%	1247
2023 Q3	$378K	Hold	121,200	–	–	﹤0.01%	1379
2023 Q2	$556K	Buy	121,200 +4,700	+4%	+$21.6K	﹤0.01%	1224
2023 Q1	$576K	Buy	116,500 +27,700	+31%	+$136K	﹤0.01%	1219
2022 Q4	$484K	Buy	88,800 +28,300	+47%	+$174K	﹤0.01%	1337
2022 Q3	$393K	Buy	60,500 +35,700	+144%	+$199K	﹤0.01%	1411
2022 Q2	$117K	Hold	24,800	–	–	﹤0.01%	1733
2022 Q1	$173K	Buy	24,800 +21,200	+589%	+$145K	﹤0.01%	1740
2021 Q4	$36K	Hold	3,600	–	–	﹤0.01%	2051
2021 Q3	$43K	Buy	+3,600	New	+$54.3K	﹤0.01%	2093

Other funds holding MXCT

CFM

Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return

Vitruvian Partners London, United Kingdom $201M AUM 10.44% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Mudita Advisors London, United Kingdom $481M AUM 73.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BFM

Brooklands Fund Management London, United Kingdom $128M AUM

BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

CCM

Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return

PLC

Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return

STRS Ohio's MXCT Position: Q2 2026 in Review

STRS Ohio sold out of MaxCyte (MXCT) in Q2 2026, closing a stake of 129,500 shares — an estimated $91K sold.

STRS Ohio first reported a position in MXCT in Q3 2021 and held it in 19 quarters. The position peaked at $576K in Q1 2023. 123 funds tracked by Wall St. Rank hold MXCT as of Q2 2026.

STRS Ohio reported no remaining MaxCyte position as of Q2 2026 after selling out during the quarter.
STRS Ohio sold 129,500 MaxCyte shares in Q2 2026, an estimated $91K.
STRS Ohio first reported a position in MaxCyte in Q3 2021 and held it in 19 quarters.
STRS Ohio's MaxCyte position peaked at $576K in Q1 2023.
123 funds tracked by Wall St. Rank held MaxCyte as of Q2 2026.

Based on STRS Ohio's 13F filing for Q2 2026, filed 30 Jul 2026.